The India sepsis diagnostics market is projected to register a CAGR of 8.80%, over the forecast years. The country’s market growth is principally accredited to the increased incidence of sepsis, the rising number of deaths associated with it, the lack of specific treatments, and reduced awareness of the medical condition across rural areas. The base year considered for the studied market is 2020, and the forecast years are from 2021 to 2026.
INDIA SEPSIS DIAGNOSTICS MARKET FORECAST 2021-2026
India Sepsis Diagnostics Market by Technology ( Microbiology, Immunoassay, Molecular Diagnostics, Other Technologies ) Market by Diagnostic Method ( Conventional Diagnostics, Automated Diagnostics ) Market by Product ( Blood Culture Media, Assay Kits & Reagents, Instruments ) Market by Pathogen ( Gram – Positive and Gram – Negative Bacterial Sepsis, Fungal Sepsis, Other Pathogens ) Market by Testing Type ( Laboratory Testing, Point-of-care Testing )
The India sepsis diagnostics market is projected to register a CAGR of 8.80%, over the forecast years. The country’s market growth is principally accredited to the increased incidence of sepsis, the rising number of deaths associated with it, the lack of specific treatments, and reduced awareness of the medical condition across rural areas. The base year considered for the studied market is 2020, and the forecast years are from 2021 to 2026.
To learn more about this report, request a free sample copy
Presently, India has been tackling at least 750,000 sepsis cases, annually. Out of this, the total fatality rate among intensive care unit (ICU) patients is more than 12%, while severe stage sepsis patients account for around 59.26%. Patients with septic shock or severe sepsis have a mortality rate of around 40% to 60%, and the geriatric population experiences the highest fatalities. Moreover, the overall deaths from sepsis in India, each year, have nearly doubled since 1980. However, there is no particular treatment available for controlling sepsis, as far as management modalities are concerned.
Although an anti-inflammatory agent for the disease named activated protein C existed, it was withdrawn from the market owing to its high costs and related adverse effects. Besides, considering these incidences, a distinguished pharmaceutical brand in India, Bharat Serums and Vaccines Ltd, bridged the gap by launching a new anti-inflammatory therapy. Hence, these factors are set to accelerate the sepsis diagnostics market in India, during the forecast period.
Bruker Corporation, headquartered in the United States, manufactures, develops, and distributes analytical and diagnostic solutions, and scientific instruments. The company caters to a diverse range of consumers, such as, biotechnology, life science research, cell biology, applied markets, nanotechnology, clinical research, pharmaceuticals, material science research, microbiology, and in vitro diagnostics.
To request a free sample copy of this report, please complete the form below :
We offer 10% free customization including country-level data, niche applications and competitive landscape with every report.
- RESEARCH SCOPE & METHODOLOGY
- STUDY OBJECTIVES
- SCOPE OF STUDY
- METHODOLOGY
- ASSUMPTIONS & LIMITATIONS
- EXECUTIVE SUMMARY
- MARKET SIZE & ESTIMATES
- COUNTRY SNAPSHOT
- COUNTRY ANALYSIS
- KEY GROWTH ENABLERS
- KEY CHALLENGES
- KEY ANALYTICS
- IMPACT OF COVID-19 ON SEPSIS DIAGNOSTICS MARKET
- KEY INVESTMENT INSIGHTS
- PORTER’S FIVE FORCES ANALYSIS
- BUYERS POWER
- SUPPLIERS POWER
- SUBSTITUTION
- NEW ENTRANTS
- INDUSTRY RIVALRY
- OPPORTUNITY MATRIX
- VENDOR LANDSCAPE
- MARKET BY TECHNOLOGY
- MICROBIOLOGY
- IMMUNOASSAY
- MOLECULAR DIAGNOSTICS
- OTHER TECHNOLOGIES
- MARKET BY DIAGNOSTIC METHOD
- CONVENTIONAL DIAGNOSTICS
- AUTOMATED DIAGNOSTICS
- MARKET BY PRODUCT
- BLOOD CULTURE MEDIA
- ASSAY KITS & REAGENTS
- INSTRUMENTS
- MARKET BY PATHOGEN
- GRAM – POSITIVE AND GRAM – NEGATIVE BACTERIAL SEPSIS
- FUNGAL SEPSIS
- OTHER PATHOGENS
- MARKET BY TESTING TYPE
- LABORATORY TESTING
- POINT-OF-CARE TESTING
- COMPETITIVE LANDSCAPE
- KEY STRATEGIC DEVELOPMENTS
- MERGERS & ACQUISITIONS
- PRODUCT LAUNCHES & DEVELOPMENTS
- PARTNERSHIPS, CONTRACTS/AGREEMENTS & COLLABORATIONS
- BUSINESS EXPANSIONS/ APPROVALS/ ANNOUNCEMENTS
- COMPANY PROFILES
- ABBOTT LABORATORIES
- BECTON, DICKINSON AND COMPANY
- BRUKER CORPORATION
- HOFFMANN-LA ROCHE
- THERMO FISHER SCIENTIFIC INC
- KEY STRATEGIC DEVELOPMENTS
LIST OF TABLES
TABLE 1: MARKET SNAPSHOT – SEPSIS DIAGNOSTICS
TABLE 2: INDIA SEPSIS DIAGNOSTICS MARKET, BY TECHNOLOGY, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
TABLE 3: INDIA SEPSIS DIAGNOSTICS MARKET, BY TECHNOLOGY, FORECAST YEARS, 2021-2026 (IN $ MILLION)
TABLE 4: INDIA SEPSIS DIAGNOSTICS MARKET, BY DIAGNOSTIC METHOD, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
TABLE 5: INDIA SEPSIS DIAGNOSTICS MARKET, BY DIAGNOSTIC METHOD, FORECAST YEARS, 2021-2026 (IN $ MILLION)
TABLE 6: INDIA SEPSIS DIAGNOSTICS MARKET, BY PRODUCT, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
TABLE 7: INDIA SEPSIS DIAGNOSTICS MARKET, BY PRODUCT, FORECAST YEARS, 2021-2026 (IN $ MILLION)
TABLE 8: INDIA SEPSIS DIAGNOSTICS MARKET, BY PATHOGEN, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
TABLE 9: INDIA SEPSIS DIAGNOSTICS MARKET, BY PATHOGEN, FORECAST YEARS, 2021-2026 (IN $ MILLION)
TABLE 10: GRAM-NEGATIVE BACTERIA CAUSING SEPSIS
TABLE 11: GRAM-POSITIVE BACTERIA CAUSING SEPSIS
TABLE 12: INDIA SEPSIS DIAGNOSTICS MARKET, BY TESTING TYPE, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
TABLE 13: INDIA SEPSIS DIAGNOSTICS MARKET, BY TESTING TYPE, FORECAST YEARS, 2021-2026 (IN $ MILLION)
TABLE 14: LIST OF MERGERS & ACQUISITIONS
TABLE 15: LIST OF PRODUCTS LAUNCHES & DEVELOPMENTS
TABLE 16: LIST OF PARTNERSHIPS & AGREEMENTS
TABLE 17: LIST OF BUSINESS EXPANSIONS & DIVESTITURES
LIST OF FIGURES
FIGURE 1: PORTER’S FIVE FORCES ANALYSIS
FIGURE 2: OPPORTUNITY MATRIX
FIGURE 3: VENDOR LANDSCAPE
FIGURE 4: KEY INVESTMENT INSIGHTS
FIGURE 5: INDIA SEPSIS DIAGNOSTICS MARKET, BY TECHNOLOGY, IN 2020
FIGURE 6: INDIA SEPSIS DIAGNOSTICS MARKET, BY MICROBIOLOGY, 2021-2026 (IN $ MILLION)
FIGURE 7: INDIA SEPSIS DIAGNOSTICS MARKET, BY IMMUNOASSAY, 2021-2026 (IN $ MILLION)
FIGURE 8: INDIA SEPSIS DIAGNOSTICS MARKET, BY MOLECULAR DIAGNOSTICS, 2021-2026 (IN $ MILLION)
FIGURE 9: INDIA SEPSIS DIAGNOSTICS MARKET, BY OTHER TECHNOLOGIES, 2021-2026 (IN $ MILLION)
FIGURE 10: INDIA SEPSIS DIAGNOSTICS MARKET, BY DIAGNOSTIC METHOD, IN 2020
FIGURE 11: INDIA SEPSIS DIAGNOSTICS MARKET, BY CONVENTIONAL DIAGNOSTICS, 2021-2026 (IN $ MILLION)
FIGURE 12: INDIA SEPSIS DIAGNOSTICS MARKET, BY AUTOMATED DIAGNOSTICS, 2021-2026 (IN $ MILLION)
FIGURE 13: INDIA SEPSIS DIAGNOSTICS MARKET, BY PRODUCT, IN 2020
FIGURE 14: INDIA SEPSIS DIAGNOSTICS MARKET, BY BLOOD CULTURE MEDIA, 2021-2026 (IN $ MILLION)
FIGURE 15: INDIA SEPSIS DIAGNOSTICS MARKET, BY ASSAY KITS & REAGENTS, 2021-2026 (IN $ MILLION)
FIGURE 16: INDIA SEPSIS DIAGNOSTICS MARKET, BY INSTRUMENTS, 2021-2026 (IN $ MILLION)
FIGURE 17: INDIA SEPSIS DIAGNOSTICS MARKET, BY PATHOGEN, IN 2020
FIGURE 18: INDIA SEPSIS DIAGNOSTICS MARKET, BY GRAM – POSITIVE AND GRAM – NEGATIVE BACTERIAL SEPSIS, 2021-2026 (IN $ MILLION)
FIGURE 19: INDIA SEPSIS DIAGNOSTICS MARKET, BY FUNGAL SEPSIS, 2021-2026 (IN $ MILLION)
FIGURE 20: INDIA SEPSIS DIAGNOSTICS MARKET, BY OTHER PATHOGENS, 2021-2026 (IN $ MILLION)
FIGURE 21: INDIA SEPSIS DIAGNOSTICS MARKET, BY TESTING TYPE, IN 2020
FIGURE 22: INDIA SEPSIS DIAGNOSTICS MARKET, BY LABORATORY TESTING, 2021-2026 (IN $ MILLION)
FIGURE 23: INDIA SEPSIS DIAGNOSTICS MARKET, BY POINT-OF-CARE TESTING, 2021-2026 (IN $ MILLION)
- MARKET BY TECHNOLOGY
- MICROBIOLOGY
- IMMUNOASSAY
- MOLECULAR DIAGNOSTICS
- OTHER TECHNOLOGIES
- MARKET BY DIAGNOSTIC METHOD
- CONVENTIONAL DIAGNOSTICS
- AUTOMATED DIAGNOSTICS
- MARKET BY PRODUCT
- BLOOD CULTURE MEDIA
- ASSAY KITS & REAGENTS
- INSTRUMENTS
- MARKET BY PATHOGEN
- GRAM – POSITIVE AND GRAM – NEGATIVE BACTERIAL SEPSIS
- FUNGAL SEPSIS
- OTHER PATHOGENS
- MARKET BY TESTING TYPE
- LABORATORY TESTING
- POINT-OF-CARE TESTING
To request a free sample copy of this report, please complete the form below :
We offer 10% free customization including country-level data, niche applications and competitive landscape with every report.